Daymark Wealth Partners’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.88M Buy
22,047
+29
+0.1% +$2.58K 0.06% 214
2025
Q4
$1.74M Sell
22,018
-107
-0.5% -$8.39K 0.06% 212
2025
Q3
$1.77M Sell
22,125
-822
-4% -$70.1K 0.06% 209
2025
Q2
$2.09M Sell
22,947
-158
-0.7% -$14.4K 0.08% 178
2025
Q1
$2.16M Sell
23,105
-545
-2% -$48.8K 0.09% 161
2024
Q4
$2.15M Sell
23,650
-459
-2% -$43.8K 0.09% 161
2024
Q3
$2.5M Sell
24,109
-444
-2% -$45.3K 0.11% 148
2024
Q2
$2.38M Buy
24,553
+1,945
+9% +$179K 0.11% 144
2024
Q1
$2.04M Buy
22,608
+164
+0.7% +$13.9K 0.11% 130
2023
Q4
$1.79M Buy
22,444
+378
+2% +$28.4K 0.11% 134
2023
Q3
$1.57M Buy
22,066
+9,967
+82% +$745K 0.11% 136
2023
Q2
$932K Buy
12,099
+377
+3% +$29.2K 0.07% 176
2023
Q1
$881K Buy
11,722
+1,384
+13% +$103K 0.12% 141
2022
Q4
$815K Buy
+10,338
New +$775K 0.14% 111

Other funds holding CL

Daymark Wealth Partners's CL Position: Q1 2026 in Review

Daymark Wealth Partners increased its Colgate-Palmolive (CL) stake by 0.13% in Q1 2026, buying an estimated $2.58K and bringing the position to 22,047 shares worth $1.88M. The position accounts for 0.06% of the portfolio, ranked #214.

Daymark Wealth Partners first reported a position in CL in Q4 2022 and has held it in 14 quarters since. The position peaked at $2.5M in Q3 2024. 1,947 funds tracked by Wall St. Rank hold CL as of Q1 2026.

  • Daymark Wealth Partners held 22,047 shares of Colgate-Palmolive worth $1.88M as of Q1 2026.
  • Daymark Wealth Partners bought 29 Colgate-Palmolive shares in Q1 2026, an estimated $2.58K.
  • Colgate-Palmolive made up 0.06% of Daymark Wealth Partners's portfolio in Q1 2026, its #214 holding.
  • Daymark Wealth Partners first reported a position in Colgate-Palmolive in Q4 2022 and has held it in 14 quarters since.
  • Daymark Wealth Partners's Colgate-Palmolive position peaked at $2.5M in Q3 2024.
  • 1,947 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q1 2026.

Based on Daymark Wealth Partners's 13F filing for Q1 2026, filed 11 May 2026.